*GW Priority Corporation
Through this RFP, it is Pfizer’s intent to support educational programs for pediatric endocrinologists.
Projects that will be considered for Pfizer support will focus on:
- Improving the understanding of the safety and efficacy of growth hormone (GH) administered once-daily in managing patients with short stature.
- Improving the understanding of the relationship between adherence and treatment outcomes.
- Increasing awareness of the emerging science of long-acting growth hormone to improve the understanding of their efficacy, safety, and potential clinical applicability.
Deadline: September 30
Dollar Amount: The estimated total available budget related to this RFP is $300,000. Pfizer anticipates awarding 1-2 grants.
Eligibility: The following may apply: medical, dental, nursing, allied health, and/or pharmacy professional schools; healthcare institutions (both large and small); professional associations and medical societies; medical education companies; and other entities with a mission related to healthcare professional education and/or healthcare improvement.
*This is a GW Priority Corporation, please contact Joe Matope, Director, Corporate Relations, at [email protected] prior to contacting this Corporation.